JP2006204290A5 - - Google Patents

Download PDF

Info

Publication number
JP2006204290A5
JP2006204290A5 JP2005365540A JP2005365540A JP2006204290A5 JP 2006204290 A5 JP2006204290 A5 JP 2006204290A5 JP 2005365540 A JP2005365540 A JP 2005365540A JP 2005365540 A JP2005365540 A JP 2005365540A JP 2006204290 A5 JP2006204290 A5 JP 2006204290A5
Authority
JP
Japan
Prior art keywords
steap
antibody
fragment
protein
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2005365540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006204290A (ja
Filing date
Publication date
Priority claimed from US09/455,486 external-priority patent/US6833438B1/en
Application filed filed Critical
Publication of JP2006204290A publication Critical patent/JP2006204290A/ja
Publication of JP2006204290A5 publication Critical patent/JP2006204290A5/ja
Withdrawn legal-status Critical Current

Links

JP2005365540A 1999-12-06 2005-12-19 ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法 Withdrawn JP2006204290A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/455,486 US6833438B1 (en) 1999-06-01 1999-12-06 Serpentine transmembrane antigens expressed in human cancers and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001541031A Division JP4827357B2 (ja) 1999-12-06 2000-12-06 ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法

Publications (2)

Publication Number Publication Date
JP2006204290A JP2006204290A (ja) 2006-08-10
JP2006204290A5 true JP2006204290A5 (https=) 2008-01-31

Family

ID=23809010

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001541031A Expired - Lifetime JP4827357B2 (ja) 1999-12-06 2000-12-06 ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法
JP2005365540A Withdrawn JP2006204290A (ja) 1999-12-06 2005-12-19 ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法
JP2010212334A Pending JP2011062201A (ja) 1999-12-06 2010-09-22 ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001541031A Expired - Lifetime JP4827357B2 (ja) 1999-12-06 2000-12-06 ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010212334A Pending JP2011062201A (ja) 1999-12-06 2010-09-22 ヒト前立腺癌において発現されるヘビ状膜貫通抗原およびその使用方法

Country Status (12)

Country Link
EP (2) EP1642909A3 (https=)
JP (3) JP4827357B2 (https=)
AT (1) ATE456578T1 (https=)
AU (2) AU775366B2 (https=)
CA (1) CA2395053C (https=)
CY (1) CY1111034T1 (https=)
DE (1) DE60043784D1 (https=)
DK (1) DK1244705T3 (https=)
ES (1) ES2340249T3 (https=)
IL (3) IL150018A0 (https=)
PT (1) PT1244705E (https=)
WO (1) WO2001040276A2 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20060052321A1 (en) 2002-04-05 2006-03-09 Raitano Arthur B Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
US20040141975A1 (en) 1998-06-01 2004-07-22 Raitano Arthur B. Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
AU757698C (en) 1998-06-01 2004-04-08 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US7611892B2 (en) 2000-03-24 2009-11-03 President And Fellows Of Harvard College Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US7189565B2 (en) 2001-03-23 2007-03-13 Fahri Saatcioglu Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
KR20030029847A (ko) * 2000-08-24 2003-04-16 제넨테크, 인크. 종양의 진단 및 치료를 위한 조성물 및 방법
ES2537074T3 (es) * 2001-09-06 2015-06-02 Agensys, Inc. Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
JP2005534287A (ja) * 2002-04-05 2005-11-17 アジェンシス， インコーポレイテッド 癌の処置および検出において有用な９８ｐ４ｂ６との名称の核酸および対応するタンパク質
AU2003256912A1 (en) * 2002-08-16 2004-03-03 Yeda Research And Development Co. Ltd. Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
JP5840351B2 (ja) 2002-09-06 2016-01-06 アジェンシス，インコーポレイテッド 癌の処置および検出において有用な９８ｐ４ｂ６と称される、核酸および対応タンパク質
EP1605893A4 (en) * 2003-03-05 2008-08-13 Innexus Biotechnology Inc TRANS-MEMBRANE ANTIBODY-INDUCED APOPTOSIS INHIBITION
US7498298B2 (en) 2003-11-06 2009-03-03 Seattle Genetics, Inc. Monomethylvaline compounds capable of conjugation to ligands
ES2443996T3 (es) 2004-04-22 2014-02-21 Agensys, Inc. Anticuerpos y moléculas derivadas de los mismos que se unen a proteínas STEAP-1
AU2005246090A1 (en) * 2005-02-22 2005-12-01 Biomedisinsk Innovasjon As STAMP2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
JP4191189B2 (ja) 2005-12-08 2008-12-03 康生 梅津 がん関連遺伝子活性化能を有するペプチド
EP2520935A3 (en) * 2006-08-09 2013-02-13 Homestead Clinical Corporation Organ-specific proteins and methods of their use
KR20140116546A (ko) 2006-10-27 2014-10-02 제넨테크, 인크. 항체 및 면역접합체 및 이들의 용도
JP5394246B2 (ja) * 2007-03-30 2014-01-22 ジェネンテック， インコーポレイテッド 抗体及びイムノコンジュゲートとこれらの使用方法
DK2474557T3 (da) 2007-07-16 2014-11-10 Genentech Inc Anti-CD79b-antistoffer og immunkonjugater og fremgangsmåder til anvendelse
NZ583318A (en) 2007-07-16 2012-07-27 Genentech Inc Humanized anti-cd79b antibodies and immunoconjugates and methods of use
WO2009046739A1 (en) 2007-10-09 2009-04-16 Curevac Gmbh Composition for treating prostate cancer (pca)
SG187517A1 (en) 2008-01-31 2013-02-28 Genentech Inc Anti-cd79b antibodies and immunoconjugates and methods of use
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
WO2014165818A2 (en) 2013-04-05 2014-10-09 T Cell Therapeutics, Inc. Compositions and methods for preventing and treating prostate cancer
PT3262071T (pt) 2014-09-23 2020-06-16 H Hoffnabb La Roche Ag Métodos de utilização de imunoconjugados anti-cd79b
IL313511A (en) 2014-11-12 2024-08-01 Seagen Inc Compounds acting on glycans and methods of using them
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
EP3373969A4 (en) 2015-11-12 2019-08-14 Siamab Therapeutics, Inc. GLYCANINTERAGING COMPOUNDS AND METHOD OF USE
MX2019003325A (es) * 2016-09-23 2019-08-05 Regeneron Pharma Anticuerpos anti-steap2, conjugados anticuerpo-farmaco, y moleculas de fijacion al antigeno biespecificas que se fijan a steap2 y cd3, y usos de estos.
EP3541847A4 (en) 2016-11-17 2020-07-08 Seattle Genetics, Inc. COMPOUNDS INTERACTING WITH GLYCANE AND METHODS OF USE
KR102653141B1 (ko) 2017-03-03 2024-04-01 씨젠 인크. 글리칸-상호작용 화합물 및 사용 방법
SG11201909218RA (en) 2017-04-03 2019-11-28 Hoffmann La Roche Antibodies binding to steap-1
WO2019125184A1 (en) 2017-12-19 2019-06-27 Auckland Uniservices Limited Use of biomarker in cancer therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5489525A (en) * 1992-10-08 1996-02-06 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies to prostate cells
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
WO1998018489A1 (en) * 1996-10-30 1998-05-07 The Uab Research Foundation Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies
US6048970A (en) * 1998-05-22 2000-04-11 Incyte Pharmaceuticals, Inc. Prostate growth-associated membrane proteins
AU757698C (en) * 1998-06-01 2004-04-08 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
EP1140970A4 (en) * 1998-12-17 2003-10-22 Human Genome Sciences Inc 47 HUMAN SECRETED PROTEINS
US20020015950A1 (en) * 1999-07-07 2002-02-07 Karen Anne Jones Atherosclerosis-associated genes
JP2003527089A (ja) * 1999-08-17 2003-09-16 インサイト・ゲノミックス・インコーポレイテッド 膜関連タンパク質

Similar Documents

Publication Publication Date Title
JP2006204290A5 (https=)
JP2010537671A5 (https=)
JP2008541711A5 (https=)
JP2011502517A5 (https=)
AU2011360938B2 (en) Novel modulators and methods of use
RU2007147596A (ru) Моноклональные антитела и одноцепочечные фрагменты антител против клеточно-поверхностного специфического для простаты мембранного антигена
JP2015172045A5 (https=)
JP2008538289A5 (https=)
RU2006105339A (ru) Rg1 антитела и их применение
JP2009197002A5 (https=)
CA2395053A1 (en) Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
JP2012012402A5 (https=)
JP2014527398A5 (https=)
CN105813654A (zh) Tem8抗体及其用途
JP2009100745A5 (https=)
JP2011501946A5 (https=)
JP2007504280A5 (https=)
JP2015510761A5 (https=)
JP2011518773A5 (https=)
JP2005528914A5 (https=)
JP2013517464A (ja) 皮膚ｔ細胞リンパ腫の診断及び処置のための方法
JP2012505659A5 (https=)
JP2007525183A5 (https=)
RU2007140311A (ru) Антитела и родственные молекулы, связываюшиеся с белками 161p2f10b
JP2008538182A5 (https=)